Rome, Italy

Alessandro Bressan


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2003-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Alessandro Bressan in IL-6 Antagonist Peptides

Introduction

Alessandro Bressan is a notable inventor based in Rome, Italy. He has made significant contributions to the field of biochemistry, particularly in the development of IL-6 antagonist peptides. With a total of two patents to his name, Bressan's work is poised to impact pharmaceutical compositions aimed at inhibiting IL-6 activity.

Latest Patents

Bressan's latest patents focus on IL-6 antagonist peptides that can be isolated from a peptide library through a two-hybrids system. These peptides are characterized by their ability to bind to the intracellular domain of gp130 and contain at least five amino acids. The first patent details peptides that include the amino acid sequence SEQ ID NO: 6, along with their salts, functional derivatives, precursors, and analogs. The second patent also describes IL-6 antagonist peptides, which comprise amino acid sequences selected from a specific group, including SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, and SEQ ID NO: 8. Both patents emphasize the importance of providing these peptides in substantially purified form for use as active ingredients in pharmaceutical compositions targeting pathologies that require IL-6 activity inhibition.

Career Highlights

Alessandro Bressan is associated with Applied Research Systems Ars Holding N.V., where he continues to innovate in the field of biochemistry. His work has garnered attention for its potential applications in medical treatments.

Collaborations

Bressan collaborates with notable colleagues such as Ottaviano Serlupi-Crescenzi and Linda Della Pietra, contributing to a dynamic research environment that fosters innovation.

Conclusion

Alessandro Bressan's contributions to the development of IL-6 antagonist peptides represent a significant advancement in pharmaceutical research. His patents highlight the potential for new treatments that could inhibit IL-6 activity, showcasing the importance of innovation in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…